Everest Medicines Ltd (1952:HK) PT Raised to HK$91.15 at Goldman Sachs

March 23, 2021 3:19 AM EDT
Get Alerts 1952:HK Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 23 | Down: 21 | New: 24
Trade Now! 
Join SI Premium – FREE
Goldman Sachs analyst Ziyi Chen raised the price target on Everest Medicines Ltd (1952:HK) to HK$91.15 (from HK$75.80) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Intl Ratings